Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.97% Passive Stake in Mama's Creations Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.97% of Mama's Creations Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.8% Stake in MaxCyte, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 7.8% of MaxCyte, Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 17.6% of Nextracker Inc.'s Class A Common Stock as of December 31, 2024.
NYSE
BlackRock, Inc. has disclosed an increased passive beneficial ownership in PTC Inc., now holding 10.2% of the common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in PAR PACIFIC HOLDINGS, Inc., Disclosing 17.1% Passive Ownership
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 17.1% of PAR PACIFIC HOLDINGS, INC.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 3.5% Passive Stake in Personalis, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.5% in Personalis, Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.1% Stake in Recursion Pharmaceuticals
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.1% beneficial ownership stake in Recursion Pharmaceuticals, Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 9.0% of Schneider National, Inc.'s Class B Common Stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Shoals Technologies Group, Disclosing 19% Passive Ownership
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 19.0% passive beneficial ownership stake in Shoals Technologies Group, Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 3.5% beneficial ownership stake in UWM Holdings Corp's Class A Common Stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.6% beneficial ownership stake in Vertex, Inc.'s Class A Common Stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Virgin Galactic Holdings Stake, Discloses 6.8% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.8% beneficial ownership stake in Virgin Galactic Holdings, Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 17.4% beneficial ownership in Xencor Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.9% Passive Stake in Amentum Holdings Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.9% passive beneficial ownership stake in AMENTUM HOLDINGS INC. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in American Superconductor, Disclosing 8.7% Ownership
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.7% of American Superconductor Corp.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.6% Stake in Anika Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 10.6% of Anika Therapeutics Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.8% of Pangaea Logistics Solutions Ltd.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Passive 4.9% Stake in i-80 Gold Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.9% of i-80 Gold Corp's common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.3% Stake in MAG Silver Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 12.3% of MAG Silver Corp's common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.3% of Mind Medicine (MindMed) Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.3% Stake in Skeena Resources Ltd.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 7.3% of Skeena Resources Ltd.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 13.3% Stake in Eldorado Gold Corporation
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 13.3% of Eldorado Gold Corporation's common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 5.3% of Pagaya Technologies Ltd.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.7% beneficial ownership in XPENG INC.'s Class A Common Stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.1% Passive Stake in PagSeguro Digital Ltd
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.1% beneficial ownership stake in PagSeguro Digital Ltd as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Reduces Passive Stake in Aemetis, Inc. to 4.9%
BlackRock, Inc. has filed an amended Schedule 13G, reporting a reduction in its passive beneficial ownership stake in Aemetis, Inc. to 4.9% as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.8% of Berry Corp's common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Discloses 4.9% Passive Stake in eGain Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership stake in eGain Corp as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.3% Stake in AG Mortgage Investment Trust
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 8.3% of the common stock of AG Mortgage Investment Trust Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, reporting a 4.97% beneficial ownership stake in Utah Medical Products Inc. as of December 31, 2024, held for ordinary course of business purposes.